The OWise breast cancer app is the first mobile app to offer patients personalised medical support throughout their treatment. A recent validation study, published in the Journal of Medical Internet Research – Cancer, has supported the use of the app, showing it improves patient-doctor interactions and reporting that 90% of patients and clinicians would recommend it.
The adoption of the OWise breast cancer app has been made possible by the NHS Innovation Accelerator (NIA) programme that awarded the creator, Dr Anne Bruinvels, a fellowship, supporting the roll-out of the app across the NHS.
Speaking about the study, OWise app inventor and CEO Dr Anne Bruinvels said “We’re thrilled that the results in the Journal of Medical Internet Research – Cancer validate what we’ve been hearing from patients and clinicians since we launched in 2013, and we hope to be able to provide this free tool to as many breast cancer patients as possible.”
Read more about the OWise app. Find out more about the NIA and follow the programme on twitter.